UCM uscom limited

0.00%

1.9¢

Why we are not selling in India?, page-5

First 5 Last

Share
Profile

Follow
Bullrush007

6,121 Posts.

745

11/05/21

13:45

Post #: 53094079
Share

Originally posted by honeysoy: ↑

Agree tumby , very frustrating as fundamentally based on a tiny mkt cap of just over $20 mill and the sales and revenue numbers it’s a compelling story with potentially enormous upside. Unfortunately the drop in revenue last quarter , current political situation between oz and China has scared everyone away and they are probably not returning. The ceo has mentioned in webinars that it’s more at a political level however the only proof that he is correct will be in sales and last quarter didn’t back up his comments.
Other than the obvious of announcing increased sales and revenues and new deals He needs to find some new large Chinese investors whom understand his vision in China and the potential as convincing sophisticated investors over here to purchase shares looks to have failed even after the last few positive announcements.
the ehealth (apple - Microsoft) comment he made is interesting and would create a new herd of interest but realistically it’s probably just more false hope.
walls of selling at 15-15.5 -16c points to our pain not easing for quite a while yet.
my belief that as the products were best in class and life saving that the sales and revenues would just automatically follow was my error .
nilnoony has thankfully given me the reality check that the 1a product got very little sales traction anywhere in recent years other than China even though the product itself is world class .,
hopefully mr Phillips hard work , confidence and contacts will lead to the deserved success but at the moment nobody believes him .

Expand

’potentially enormous upside’

But the company hasn’t reported on any future earnings

All unsubstantiated hype unless someone in the company ‘puts their balls on the line’ with commercial targets to be achieved in a certain timeframe

UCM Price at posting: 14.5¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $4.759M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	500000	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	46000	1

View Market Depth

No.	Vol.	Price($)
1	500000	0.014
1	132270	0.012
1	100000	0.010
1	150000	0.008
2	2000000	0.001

Price($)	Vol.	No.
0.019	46000	1
0.020	63256	1
0.021	24866	1
0.022	6549	1
0.055	95083	2

Last trade - 16.21pm 27/06/2025 (20 minute delay)

UCM (ASX) Chart

Day chart unavailable

Why we are not selling in India?, page-5

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Why we are not selling in India?, page-5

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News